Latest Milo Biotechnology Stories
CLEVELAND and COLUMBUS, Ohio, Dec.
The Duchenne Alliance commits $500,000 to Jerry Mendell M.D. and Milo Biotechnology to fund first Duchenne Follistatin Gene Therapy Trial
COLUMBUS, Ohio, Nov. 17, 2014 /PRNewswire/ -- The International Duchenne Alliance announced today that it will allocate $500,000 to Jerry Mendell, M.D.
Milo Biotechnology's Follistatin Gene Therapy Increases Function in Becker Muscular Dystrophy Patients
CLEVELAND and COLUMBUS, Ohio, Oct.
Word of the Day
- Emitting flashes of light; glittering.
The word 'coruscant' comes from a Latin word meaning 'to flash' or 'to sparkle'.